Alcon (ALC) Capital Expenditures (2009 - 2026)
Alcon (ALC) posted Capital Expenditures of -$96.0 million for Q2 2026, up 30.94% on a QoQ basis from -$139.0 million in Q1 2026, and up 5.88% year-over-year from -$90.7 million in Q2 2025.
Analysis
Alcon (ALC) Capital Expenditures (2009 - 2026) Analysis & Trends
Alcon has reported Capital Expenditures for 11 years, with the latest figure at -$96.0 million in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 5.88% year-over-year to -$96.0 million in Q2 2026; TTM through Jun 2026 was -$545.0 million, a 73.57% decrease from a year earlier, with the FY2025 full-year figure at -$543.0 million, down 14.8% from the prior year.
- Capital Expenditures was -$96.0 million for Q2 2026 at Alcon, up from -$139.0 million in the prior quarter.
- The five-year high for Capital Expenditures was -$2.0 million in Q4 2023, with the low at -$239.0 million in Q4 2022.
- Average Capital Expenditures over 5 years is -$114.9 million, with a median of -$118.0 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures jumped 99.16% in 2023, then sank 7100.0% in 2025.
- Over 5 years, Capital Expenditures stood at -$239.0 million in 2022, then surged by 99.16% to -$2.0 million in 2023, then changed by 0.0% to -$2.0 million in 2024, then tumbled by 7100.0% to -$144.0 million in 2025, then soared by 33.33% to -$96.0 million in 2026.
- The last three Capital Expenditures figures came in at -$96.0 million (Q2 2026), -$139.0 million (Q1 2026), and -$144.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -96.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Dec 31, 2025 | -144.00 Mn |
| Sep 30, 2025 | -166.00 Mn |
| Jun 30, 2025 | -102.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -118.00 Mn |
| Jun 30, 2024 | -92.00 Mn |
| Mar 31, 2024 | -112.00 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Sep 30, 2023 | -124.00 Mn |
| Jun 30, 2023 | -117.00 Mn |
| Mar 31, 2023 | -104.00 Mn |
| Dec 31, 2022 | -239.00 Mn |
| Sep 30, 2022 | -160.00 Mn |
| Jun 30, 2022 | -119.00 Mn |
| Mar 31, 2022 | -118.00 Mn |
| Dec 31, 2021 | -320.00 Mn |
| Sep 30, 2021 | -158.00 Mn |
| Jun 30, 2021 | -114.00 Mn |